Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Ping Liao

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|December 29, 2012
LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancerTai-Kuang Chao, Yi-Te Yo, Yu-Ping Liao, et al.
Journal of Gynecologic Oncology|November 30, 2017
The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapingsCheng Chang Chang, Hui Chen Wang, Yu Ping Liao, et al.
The American Journal of Pathology|January 7, 2012
ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcomeYu-Chi Wang, Yi-Te Yo, Hsin-Yi Lee, et al.
Annals of Translational Medicine|November 4, 2021
Retrospective validation of 11-13 weeks' gestation ultrasound characteristics as predictive tools for twin-twin transfusion syndrome and selective intrauterine growth restriction in monochorionic diamniotic twin pregnanciesYin-Di Zhu, Jin-Yan Bian, Yu-Ping Liao, et al.
Oncotarget|September 9, 2017
An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patientsPing-Ying Chang, Yu-Ping Liao, Hui-Chen Wang, et al.
Plos One|July 29, 2017
Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancerTai-Kuang Chao, Tien-Shuo Huang, Yu-Ping Liao, et al.
Clinical Epigenetics|August 25, 2015
Triage of high-risk human papillomavirus-positive women by methylated POU4F3Par Bahadur Pun, Yu-Ping Liao, Po-Hsuan Su, et al.
Cancer|June 22, 2010
Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worseHung-Cheng Lai, Ya-Wen Lin, Rui-Lan Huang, et al.
BMC Cancer|May 20, 2015
Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasmCheng-Chang Chang, Rui-Lan Huang, Yu-Ping Liao, et al.
International Journal of Cancer|December 7, 2013
Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancerYu-Chih Chen, Rui-Lan Huang, Yung-Kai Huang, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|December 29, 2012
LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancerTai-Kuang Chao, Yi-Te Yo, Yu-Ping Liao, et al.
Journal of Gynecologic Oncology|November 30, 2017
The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapingsCheng Chang Chang, Hui Chen Wang, Yu Ping Liao, et al.
The American Journal of Pathology|January 7, 2012
ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcomeYu-Chi Wang, Yi-Te Yo, Hsin-Yi Lee, et al.
Annals of Translational Medicine|November 4, 2021
Retrospective validation of 11-13 weeks' gestation ultrasound characteristics as predictive tools for twin-twin transfusion syndrome and selective intrauterine growth restriction in monochorionic diamniotic twin pregnanciesYin-Di Zhu, Jin-Yan Bian, Yu-Ping Liao, et al.
Oncotarget|September 9, 2017
An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patientsPing-Ying Chang, Yu-Ping Liao, Hui-Chen Wang, et al.
Plos One|July 29, 2017
Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancerTai-Kuang Chao, Tien-Shuo Huang, Yu-Ping Liao, et al.
Clinical Epigenetics|August 25, 2015
Triage of high-risk human papillomavirus-positive women by methylated POU4F3Par Bahadur Pun, Yu-Ping Liao, Po-Hsuan Su, et al.
Cancer|June 22, 2010
Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worseHung-Cheng Lai, Ya-Wen Lin, Rui-Lan Huang, et al.
BMC Cancer|May 20, 2015
Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasmCheng-Chang Chang, Rui-Lan Huang, Yu-Ping Liao, et al.
International Journal of Cancer|December 7, 2013
Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancerYu-Chih Chen, Rui-Lan Huang, Yung-Kai Huang, et al.
Pageof 3